Da Volterra
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
398 2,285Activities
Technologies
Entity types
Location
172 Rue de Charonne Bât B1 - 4e, 75011 Paris, France
Paris
France
Employees
Scale: 11-50
Estimated: 7
SIREN
431860758Engaged corporates
5
2 2Added in Motherbase
5 years, 1 month ago
biotech Value proposition
Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field.
Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field.
Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases.
We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives.
Committed to innovation, Da Volterra develops products intended to protect the intestinal microbiota or harness its potential to help prevent and cure human diseases. Over the years since inception, we have gathered a unique in-house expertise on the intestinal microbiota and its links to the different body functions, antibacterial drugs and other drugs disrupting the microbiota as well as drug delivery technologies.
biotechnologie, drug development, drug research, and microbiologyOriginal language
Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field.
Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field.
Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases.
We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives.
Committed to innovation, Da Volterra develops products intended to protect the intestinal microbiota or harness its potential to help prevent and cure human diseases. Over the years since inception, we have gathered a unique in-house expertise on the intestinal microbiota and its links to the different body functions, antibacterial drugs and other drugs disrupting the microbiota as well as drug delivery technologies.
HGO909 👅 Bandar Slot Gacor Terpercaya Mudah Bermain Slot Gacor Sering Maxwin
HGO 909 Merupakan situs bandar slot terpercaya yang peroperasi dalam menyediakan situs slot gacor khusus game pragmatic play dan pGsoft, jadi sobat semua jangan ragu untuk bermain di hgo909.
https://davolterra.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 3 Jun 2020 | | |
 Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 22 Aug 2016 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Not capitalistic Not partnership Event 21 Jun 2019 | | |
 bioMérieux Biotechnology, Biotechnology Research | bioMérieux Biotechnology, Biotechnology Research | Not capitalistic Not partnership Event 19 Jan 2017 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Not capitalistic Partnership Event 24 May 2022 | | |